Top Links

Articles Related to APM

Responses and Survival under Pegylated Interferon α2a Treatment for Patients with Post-MPN Acute Myeloid Leukemia and Acute Panmyelosis with Myelofibrosis

We report here for the first time the efficacy of pegylated interferon α2a (Peg-Ifn) as a therapy for patients with myelofibrosis and high blast counts. We treated four patients who were in an accelerated phase of myeloproliferative neoplasms or acute panmyelosis with myelofibrosis using only this drug.
View complete article: PDF  |  Full-text

Langerhans Cell Histiocytosis in a Patient with Lynch Syndrome (Hereditary Non Polyposis Colorectal Cancer)

A fifty three year old white female smoker with Lynch Syndrome was receiving adjuvant chemotherapy for node positive caecal adenocarcinoma. Interval investigations demonstrated a second primary gastric cancer with bilateral pulmonary nodules of indeterminate significance. Lung biopsy revealed Langerhans cell histiocytosis (LCH).
View complete article: PDF  |  Full-text

SLNs Based on Co-Processed Lipids for Topical Delivery of Terbinafine Hydrochloride

Terbinafine hydrochloride (TH) is first line drug against treatment of onychomycosis; which is the commonest fungal infection of nail plate. However, strong barrier property of nail plate restricts the effective topical treatment of onychomycosis. In this study, TH loaded solid lipid nanoparticles (SLNs) were prepared and subsequently incorporated into a gel system. SLNs were prepared by high pressure homogenization (HPH) technique using glyceryl monosterate (GMS), compritol 888ATO and a co-processed lipid. They were evaluated for particle size, polydispersity index, zeta potential, % entrapment efficiency (%EE), % drug loading (%DL), drug content and in-vitro drug release. Optimized SLNs were incorporated into chitosan gel and further evaluated for in-vitro drug release and ex-vivo antifungal study.
View complete article: PDF  |  Full-text

Liposphere: A Versatile Controlled Release Carrier for Hydrophobic Drugs

Researchers have been inventing new drugs since time immemorial. Of late it is established that the development of new drugs alone is not sufficient to ensure progress in drug therapy. The missing link is a potential strategy.It involves the apt selection of drug carrier systems.
View complete article: PDF  |  Full-text  | Digital
 
 

Topical Delivery System for Phytochemicals: Capsaicin and Capsicum Tincture

Capsaicin, an active ingredient of Capsicum fruit, is currently undergoing “revival” in the clinical management of pain. However, the choice of its formulation is rather limited to the use of “old-fashioned” tinctures and recently the patches. In an attempt to improve the therapeutic outcome and develop its skin-friendly formulation, we prepared the vesicle-based drug delivery system with capsaicin.
View complete article: PDF  |  Full-text  | Digital
 
 


Editorial Board Members Related to APM

Suresh G. Joshi

Associate Professor
Department of Microbiology and Immunology
Drexel University
United States

Alfio Ferlito

Professor
Department of Surgical Sciences
University of Udine
Italy.

GEORGE K. PARASKEVAS

Associate Professor
Department of Anatomy
Aristotle University of Thessaloniki
Greece

George K. Paraskevas

Associate Professor
Department of Anatomy
Faculty of Medicine
Aristotle University of Thessaloniki
Greece

Alfio Ferlito

Professor
Department of Otolaryngology
University of Udine School of Medicine
Italy

MICHAEL CHAPMAN

Professor
Department of Obstetrics and Gynecology
School of Women's and Children's Health
University of New South Wales
Australia
Submit Manuscript


Open Access Journals

View All Journals